CURRENT VIEWS ON TOXIC HEPATITIS DRUG-INDUCED
Abstract
Damage to the liver caused by drugs or non-drug substances is called hepatotoxicity. The risk of developing hepatotoxicity is due to several factors, including individual intolerance, gender, alcohol consumption of smoking concomitant other medications, presence of liver disease, and genetic and environmental characteristics [4]. Although most lipophilic drugs are capable of causing liver damage, antibiotics nonsteroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants stand out as the most frequent provocateurs of hepatotoxicity. Intravenously administered drugs, such as antibiotics and tumour drugs, also show the strongest association with hepatic toxicity
Downloads
References
Бабаджанов А. С. и др. Патология коагуляционного гемостаза при циррозе печени и COVID-19 //Вестник Ташкентской медицинской академии. – 2021. – №. 1. – С. 15-16.
Курбонова З. Ч., Бабаджанова Ш. А. Нарушение системы гемостаза при хронических диффузных заболеваниях печени: монография //Тошкент," Ҳилол нашр" босмахонаси. – 2021. – С. 106-108.
Tairova G. B., Ch K. Z. Improvement Of Laboratory Diagnosis Of Autoimmune Hepatitis //Galaxy International Interdisciplinary Research Journal. – 2022. – Т. 10. – С. 1667-1671.
Каримов Х.Я., и др. Механизмы нарушений при токсическом повреждении печени и пути их коррекции с помощью нового аминокислотного раствора на основе сукцината натрия и маннитола // Журнал теоретической и клинической медицины-2021. - №3.
Сайфутдинова З.А. Современные представления о гипоксии-индуцибельном факторе-1 (hif-1) – важном звене в патогенезе ишемических повреждений тканей // Вестник Ташкентской медицинской академии-2021. - №3.
Сайфутдинова З.А., Каримов Х.Я., Саидов А.Б. Патофизиологическое обоснование применения новой аминокислотной смеси при повреждении печени // Тиббиётда янги кун-2021. - №4. –Б. 93-96.
Negmatov, S., Rahmonov, B., Sobirov, B., Abdullaev, A., Salimsakov, Y., Negmatov, J., ... & Mahkamov, D. (2012). Developing of Effective Multipurpose Polymer-Bitumen Compositions. Advanced Materials Research, 413, 539-540.
Negmatov, S., Rahmonov, B., Sobirov, B., Abdullaev, A., Salimsakov, Y., Negmatov, J., ... & Mahkamov, D. (2012). Developing of Effective Multipurpose Polymer-Bitumen Compositions. Advanced Materials Research, 413, 539-540.
Baxtiyorovich, R. B. (2025). SIYDIK TOSH KASALLIGINING EPIDEMIOLOGIYASI. PEDAGOGICAL SCIENCES AND TEACHING METHODS, 4(43), 428-430.
Baxtiyor o'g'li, R. B. (2024). POSTOPERATIVE COMPLICATIONS OF BENIGN PROSTATIC HYPERPLASIA: A COMPREHENSIVE REVIEW. Interdisciplinary Journal of Chemical Biology and Medicine, 1(1), 27-28.
Raxmonov, S. (2025). THE ROLE OF CLINICAL LABORATORY AND PATHOLOGICAL PHYSIOLOGY IN DETERMINING ANTI-NUCLEAR ANTIBODIES (ANK) TITER. International journal of medical sciences, 1(2), 311-315.
Oybek o‘g‘li, R. S. O’TKIR LEYKOZNING MOLEKULYAR DIAGNOSTIKASIDAGI AXAMIYATI.
Raxmonov, S. (2025). O’TKIR LEYKOZNING MOLEKULYAR DIAGNOSTIKASIDAGI AXAMIYATI. Modern Science and Research, 4(3), 1683-1690.
Oybek o’g’li, R. S. (2025, February). THE ROLE OF NEOROTRANSMITTERS IN PAIN AND ITS MANAGEMENT IN THE BODY. In International Conference on Modern Science and Scientific Studies (pp. 318-322).
Oybek o’g’li, R. S. (2024). THE IMPORTANCE OF LABORATORY RESULTS IN THE TREATMENT OF LIVER DISEASE. Multidisciplinary and Multidimensional Journal, 3(10), 67-74.
Raxmonov, S. (2025). ANTI-TUOR IMMUNITY. ONCOMARKERS. Modern Science and Research, 4(3), 637-642.
Oybek o'g'li, R. S. (2025). ANTI-TUOR IMMUNITY. ONCOMARKERS.
Oybek o’g’li, R. S. (2025). CANCER NOMENKLATURE AND SUSTAINED PROLIFERATIVE SIGNALING. Web of Medicine: Journal of Medicine, Practice and Nursing, 3(2), 413-417.
